We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
Free and impartial help with money and pensions.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Oct - 31 Dec 2023.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Data sources of numbers relating to the coronavirus pandemic in the UK.
How to use a case-control study to evaluate your digital health product.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Find out how interest is calculated and applied if you have a Plan 1 student loan, as well as previous interest rates.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Advice and guidance on the health needs of migrant patients from Ecuador for healthcare practitioners.
Explainer on product information templates to be used by applicants and Marketing Authorisation Holders (MAHs) of veterinary medicines.
Advice and guidance on the health needs of migrant patients from Dominica for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Honduras for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from the Dominican Republic for healthcare practitioners.
How to write up and share your findings
Find UK trade data from HMRC. Look up data about imports, exports, commodities and traders.
The epidemiology, symptoms, diagnosis and management of Nipah virus infections.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.